Stock Price
1.47
Daily Change
-0.04 -2.65%
Monthly
11.36%
Yearly
-51.32%
Q1 Forecast
1.33

Geron reported $-18.43M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Amgen USD 1.33B 1.88B Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Cytokinetics USD -306.18M 171.81M Sep/2025
Exelixis USD 193.58M 8.73M Sep/2025
Genmab DKK 336M 141M Jun/2025
Geron USD -18.43M 2.05M Sep/2025
Gilead Sciences USD 3.05B 1.09B Sep/2025
Incyte USD 424.17M 19.17M Sep/2025
MacroGenics USD 16.82M 53.07M Sep/2025
Novartis USD 3.93B 96M Sep/2025